Amedisys Inc logo

AMED - Amedisys Inc Share Price

$180.31 -1.0  -0.6%

Last Trade - 17/01/20

Sector
Healthcare
Size
Large Cap
Market Cap £4.47bn
Enterprise Value £4.64bn
Revenue £1.44bn
Position in Universe 1091st / 6416
Bullish
Bearish
Unlock AMED Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

AMED Revenue Unlock AMED Revenue

Net Income

AMED Net Income Unlock AMED Revenue

Normalised EPS

AMED Normalised EPS Unlock AMED Revenue

PE Ratio Range

AMED PE Ratio Range Unlock AMED Revenue

Dividend Yield Range

AMED Dividend Yield Range Unlock AMED Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
AMED EPS Forecasts Unlock AMED Revenue
Profile Summary

Amedisys, Inc. is a healthcare services company. The Company's segments are Home Health, Hospice, Personal Care and Other. The Company is a provider of home health, hospice and personal care services. The Company owns and operates approximately 479 centers in 38 states and the District of Columbia. The Company's Home Health segment provides compassionate healthcare to help its patients recover from surgery or illness, live with chronic diseases, and prevent avoidable hospital readmissions. The Hospice segment provides support for those who are dealing with a terminal illness, such as heart disease, pulmonary disease, Alzheimer's and Human Immunodeficiency Virus (HIV)/Acquired Immuno Deficiency Syndrome (AIDS). The Personal care segment provides patients with assistance with the essential activities of daily living.

Directors
Last Annual December 31st, 2018
Last Interim September 30th, 2019
Incorporated June 28, 1994
Public Since August 17, 1994
No. of Shareholders: 510
No. of Employees: 21,000
Sector Healthcare
Industry Healthcare Providers & Services
Index S&P 400 Mid Cap , Nasdaq Composite , S&P Composite 1500 ,
Exchange NASDAQ Global Select Market
Shares in Issue 32,255,257
Free Float (0.0%)
Eligible for
ISAs
SIPPs
AMED Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for AMED
Upcoming Events for AMED
Similar to AMED
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.